Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -7.29% is 67% above its 5-year average of -21.79%, near the high end of its 5-year range (-58.40%–-4.18%).
39.40% above its 12-month average of -12.03%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -1.74%.
RETURN ON ASSETS (ROA)
-7.29%
RETURN ON ASSETS (ROA) AVG TTM
-12.03%
RETURN ON ASSETS (ROA) AVG 3Y
-16.66%
RETURN ON ASSETS (ROA) AVG 5Y
-21.79%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+39.40%
CURRENT VS 3Y AVG
+56.23%
CURRENT VS 5Y AVG
+66.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+77.39%
vs the sector median at left
10x Genomics, Inc.
Market Cap
$10.20B
Return on Assets (ROA)
-7.29%
TTM Avg
-12.03%
3Y Avg
-16.66%
5Y Avg
-21.79%
Market Cap
$10.21B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.14B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$10.12B
Return on Assets (ROA)
-157.89%
TTM Avg
-89.00%
3Y Avg
-102.14%
5Y Avg
-97.13%
Market Cap
$10.30B
Return on Assets (ROA)
9.76%
TTM Avg
6.05%
3Y Avg
5.92%
5Y Avg
6.23%
Market Cap
$10.03B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
Market Cap
$10.39B
Return on Assets (ROA)
-20.33%
TTM Avg
-23.04%
3Y Avg
-23.77%
5Y Avg
-25.30%
Market Cap
$9.93B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$9.89B
Return on Assets (ROA)
1.41%
TTM Avg
0.38%
3Y Avg
2.34%
5Y Avg
2.99%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 10x Genomics, Inc. (TXG) | $10.20B | -7.29% | -12.03% | -16.66% | -21.79% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | -0.04% | 5.29% | 6.08% | 6.13% |
| Align Technology, Inc. (ALGN)vs › | $10.14B | 6.44% | 6.68% | 6.69% | 12.75% |
| ImmunityBio, Inc. (IBRX)vs › | $10.12B | -157.89% | -89.00% | -102.14% | -97.13% |
| Globus Medical, Inc. (GMED)vs › | $10.30B | 9.76% | 6.05% | 5.92% | 6.23% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 6.59% | 6.34% | 6.05% | 6.29% |
| Twist Bioscience Corporation (TWST)vs › | $10.39B | -20.33% | -23.04% | -23.77% | -25.30% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 2.17% | -6.26% | -11.14% | 1.46% |
| Repligen Corporation (RGEN)vs › | $9.89B | 1.41% | 0.38% | 2.34% | 2.99% |
| Universal Health Services, Inc. (UHS)vs › | $10.70B | 9.58% | 8.61% | 6.84% | 6.99% |
ROA
-7.3%
ROE
-9.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -4.18% |
| 2024-12-31 | -19.88% |
| 2023-12-31 | -26.43% |
| 2022-12-31 | -16.13% |
| 2021-12-31 | -5.71% |
| 2020-12-31 | -58.40% |
| 2019-12-31 | -5.16% |
| 2018-12-31 | -90.49% |
| 2017-12-31 | -24.81% |
